| Heinrich, Peter (Alira Health 202005 Partner + Sinfonie LS 201206– Managing Director before MagForce + MediGene) |
Managing Director |
Alira Health (CMC Consulting Boston) (Group) |
Germany |
| Heinrichs, Hubert (Antisense Pharma 201012 Managing Director) |
Managing Director |
Isarna Therapeutics GmbH |
Germany |
| Heintze, Déborah (Lunaphore Technologies 201404– COO + Co-Founder) |
Chief Operating Officer (COO) |
Lunaphore Technologies S.A. |
Switzerland |
| Heinz, Dirk (Helmholtz 201108– Scientific Director of HZI Braunschweig since 1998 at GBF/HZI) |
President/Director/Head Business Group/Unit/Division |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Heinze-Krauss, Ingrid (Basilea 2000–201601 joined at founding 2000 + will retire 201601) |
Chief Technology/Technical Officer (CTO) |
Basilea (Group) |
Switzerland |
| Heinzen, Christoph (Alicon AG 200810 CEO) |
Chief Executive Officer (CEO) |
Alicon AG |
Switzerland |
| Heise, Tim (Profil GmbH 201403 Managing Director) |
Managing Director |
Profil Institut für Stoffwechselforschung GmbH |
Germany |
| Helbig, Ingo (Univ Kiel 201203 Professor Dept of Neuropediatrics UKSH Kiel) |
Professor |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Helbling, Paul (Dualsystems Biotech 201309 Business Development Sales and Marketing) |
Business Development Manager / Strategy Manager |
Dualsystems Biotech (Group) |
Switzerland |
| Heldt, Markus (BASF 201310 President of Crop Protection division) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
| Helfenstein, Roland (Numab 2011– CFO) |
Chief Financial Officer (CFO) |
Numab (Group) |
Switzerland |
| Helftenbein, Elke (Antigene Biotech GmbH –201201 Managing Director) |
Managing Director |
Antigene Biotech GmbH |
Germany |
| Hélin, Guy (Syngulon 201809 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Syngulon S.A. |
Belgium |
| Hell, Stefan W. (Max Planck 201503 Director at MPI for biophysical Chemstry in Göttingen) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Helle, Norbert (TeLa GmbH 200902 Managing Director) |
Managing Director |
Sirius Fine Chemicals SiChem GmbH |
Germany |
| Heller, Barbara (Santhera 200701 CFO) |
Chief Financial Officer (CFO) |
Santhera (Group) |
Switzerland |
| Heller, Damian (Basilea 201708– General Counsel + Corp Secretary joined 2015 before Novartis Pharma + Syngenta) |
General Counsel / Chief Legal Officer (CLO) |
Basilea (Group) |
Switzerland |
| Heller, Manfred (Univ Bern 201109 Head Proteomics + Mass Spec Core Facility) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bern |
Switzerland |
| Hellmann, Arndt (CMS 201408 Head of Public & Media Relations CMS Hasche Sigle Berlin) |
Public Relations Manager / Investor Relations Manager |
CMS (Group) |
Germany |
| Hellmann, Carsten (ALK 201701– CEO before Sanofi SVP CEO of Merial) |
Chief Executive Officer (CEO) |
ALK (Group) |
Denmark |
| Hellwage, Jens (InfectoGnostics 201504 Managing Director) |
Cluster Manager |
InfectoGnostics Research Campus Jena (InfectoGnostics Forschungscampus Jena e. V. ) |
Germany |
| Helma-Smets, Jonas (Tubulis 201907– Managing Director (CSO) + Co-Founder) |
Managing Director |
Tubulis GmbH |
Germany |
| Helmling, Steffen (Noxxon 200603 VP BusDev US) |
Business Development Manager / Strategy Manager |
Noxxon Pharma AG |
Germany |
| Heltovics, Gábor (Druggability Technologies 201406 CEO before Solvo Biotechnology 200603 Director BusDev) |
Chief Executive Officer (CEO) |
Druggability Technologies (DRGT) (Group) |
Ireland, Republic of |
| Hemker, Claus (CTC North 202002 Head of Business Development before SCOPE Life Sciences 201004 Managing Director) |
Business Development Manager / Strategy Manager |
CTC North (Group) |
Germany |
| Hemme, Philip (Labiotech.eu 201506–201906 CEO + Co-Founder RESIGNED 6/19) |
Company Founder |
Labiotech.eu UG (haftungsbeschränkt) |
Germany |
| Henchoz, Stéphane (Auven Therapeutics 201409– Director of Finance at ADC Therapeutics before Merck Serono) |
Chief Financial Officer (CFO) |
ADC Therapeutics (Group) |
Switzerland |
| Henco, Karsten (HS LifeSciences 200901 President + former founding investor of Qiagen + Evotec et al) |
Investment Manager |
HS LifeSciences (Group) |
Switzerland |
| Henderson, Ian (MCF Corporate Finance 201612) |
consulting (economic) |
MCF Corporate Finance |
Germany |
| Hendricson, Adam (BMS 201111 Lead Evaluation at BMS, C, US) |
Researcher (industry) |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Hendriks, Stefan (Novartis 201807 Global Head of Biopharmaceuticals at Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Hengster, Ingrid (Germany (govt) 201505 Exective Board Member of KfW) |
Board member, executive |
Germany (govt) |
Germany |
| Hengstermann, Theo (Optimare 201004 CEO) |
Chief Executive Officer (CEO) |
Aerodata (Group) |
Germany |
| Henig, Noreen Roth (201807– CMO before ProQR Therapeutics + Gilead Sciences) |
Chief Medical Officer (CMO) |
Zambon (Group) |
Germany |
| Henke, Heinz-Werner (Innovative Tomography Products GmbH 201305 Managing Director) |
Managing Director |
Innovative Tomography Products GmbH (ITP Innotom) |
Germany |
| Henkel, Thomas (IMD Natural Solutions 201508 Managing Director + Co-Founder + Imax Discovery before Bayer) |
Managing Director |
IMD Natural Solutions (INS) (Group) |
Germany |
| Henkel, Thomas (Targos Molecular Pathology GmbH 201201 Managing Director) |
Managing Director |
Targos Molecular Pathology GmbH |
Germany |
| Henn, Hans-Joachim (Bayer 201606 Global Head of Anti-Counterfeit Management) |
n. a. |
Bayer (Group) |
Germany |
| Hennecke, Anne (MC Services 201211 Managing Partner before Evotec + Schwarz Pharma) |
public relations / investor relations |
MC Services AG |
Germany |
| Hennecke, Jens (PPF Group 201503– CBO at Sotio as before Micromet VP BusDev) |
Chief Business Officer (CBO) |
PPF Group (Group) |
Czech Republic |
| Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + Co-Founder before Nexigen GmbH) |
Managing Director |
VeroVaccines GmbH |
Germany |
| Hennig, Christian (Zellkraftwerk 201301) |
Company Founder |
Bruker (Group) |
Germany |
| Henrichsen, Frank (Nanion Technologies 201601– Director of Global Sales before Sophion Bioscience) |
Sales Manager / Marketing Manager |
Nanion (Group) |
Germany |
| Hensel, Frank (High-Tech Gründerfonds 201603) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Hentsch, Bernd (4SC 201009–201403 Chief Development Officer LEFT 3/14) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Germany |
| Hentschel, Norbert (Miltenyi Biotec 201308 Managing Director) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
| Hentz, Marc W. (AMP Biosimilars AG 201505 CEO before AMP-Therapeutics GmbH 201210 Managing Director) |
Chief Executive Officer (CEO) |
AMP Biosimilars AG |
Germany |
| Hentze, Matthias W. (EMBL 201702 Director) |
President/Director/Head of Research Organisation/Unit |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Henze, Kirstin (Danaher 201104 Director Communications + Corporate Identity at Leica Microsystems) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
Germany |
| Hepberger, Rainer (Innovacell 201204– CFO) |
Chief Financial Officer (CFO) |
Innovacell Biotechnologie AG |
Austria |
| Herbeaux, Jean-Luc (Evonik 201112 Head of Health Care business) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Herberg, Axel (Gerresheimer 200703 President + CEO) |
Chief Executive Officer (CEO) |
Gerresheimer (Group) |
Germany |
| Herbers, Karin (SunGene GmbH 200502 Managing Director) |
Managing Director |
BASF (Group) |
Germany |
| Herbert, Susan Jane (Merck (DE) 201109 Head Global Portfolio Development at Merck Serono) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| Herklots, Hans (LifeSci 201805 LifeSci Advisors before Carpicorn One + TiGenix) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel) |
Chief Financial Officer (CFO) |
Bruker (Group) |
United States (USA) |
| Hermance, Frank S. (Ametek 201408 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
| Hermann, Frank (4SC 201610– promoted CDO joined recently from BMS) |
Research & Development Manager |
4SC (Group) |
Germany |
| Hermann, Ralf (Eppendorf –201610 Chief Marketing + Portfolio Manager LEFT 10/16 before Sartorius/Vivascience + Qiagen) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Hermansen, Ronny (Axis-Shield 200704– Finance Director before merger Axis Biochemicals Finance Director) |
Chief Financial Officer (CFO) |
Alere (Group) |
United Kingdom (GB) |
| Hermes, Rene (Definiens AG 200611 Vice Pres Marketing) |
n. a. |
AstraZeneca (Group) |
Germany |
| Hernday, Natasha (Seattle Genetics 201306 VP Corporate Development) |
Business Development Manager / Strategy Manager |
Seagen (Group) |
United States (USA) |
| Herndon, Russell (Hydra Biosciences 201404 CEO) |
Chief Executive Officer (CEO) |
Hydra Biosciences Inc. |
United States (USA) |
| Herpel, Kurt (Delta 4 202006 CEO) |
Chief Executive Officer (CEO) |
Delta 4 GmbH |
Austria |
| Herr, Stefan (EMBL Ventures) |
Partner (venture partner) |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Herrema, Greg (Thermo Fisher 200703 President Scientific Instruments) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Herrendorff, Ruben (Polyneuron 201805 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Polyneuron Pharmaceuticals AG |
Switzerland |
| Herrenknecht, Kurt (SciArcum 201110– before Proteros + Zukunftsfonds Heilbronn + PerkinElmer + Evotec + Eisai) |
Business Development Manager / Strategy Manager |
SciArcum Biotech Consulting – Dr. Kurt Herrenknecht |
Germany |
| Herrmann, Alexander (Gilupi GmbH 201605– Managing Director before Capsulution + Metabolomic Discoveries) |
General Manager (management) |
Viroad (Group) |
Germany |
| Herrmann, Andreas (Valerius Biopharma 201805 CEO + Founder before Alvotech + Celonic + Baliopharm + Synimmune + Cardion) |
Chief Executive Officer (CEO) |
Valerius Biopharma AG |
Switzerland |
| Herrmann, Brigitte (Rheinland-Pfalz (govt) 201601 Head of Venture Capital at ISB) |
Investment Manager |
Investitions- und Strukturbank Rheinland-Pfalz (ISB) |
Germany |
| Herrmann, Max (Silence Therapeutics 201108 CFO + acting CEO beforre Intercytex 200809– CFO) |
Chief Financial Officer (CFO) |
Silence Therapeutics (Group) |
United Kingdom (GB) |
| Herrmann, Reinhard (AVISO GmbH 200711 Managing Director) |
Managing Director |
AVISO GmbH Mechatronic Systems |
Germany |
| Herrmann, Rüdiger (Mayer Brown 200809 Frankfurt/M) |
n. a. |
Mayer Brown LLP |
Germany |
| Herron, Jennifer (ADC Therapeutics 201911– CCO based in US before Immunogen + MorphoSys US + Ariad + BMS) |
Chief Commercial Officer (CCO) |
ADC Therapeutics (Group) |
United States (USA) |
| Hertig, Christina (Galenica 201112 Head Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Galenica (Group) |
Switzerland |
| Hertzberg, Suzan (Ipsogen 200810 President of Ipsogen Inc + VP Corporate BusDev) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
United States (USA) |
| Herzog, Ruth |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hess, Heribert (Tecan 2012– Manager Commercial Operations D-A-CH) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
| Hess, Matthias (AnalytiCon Discovery 200504) |
n. a. |
BRAIN (Group) |
Germany |
| Hessing, Michael |
n. a. |
Dr. Schmidt (Group) |
Germany |
| Hesslein, Robert (Bob) (Voyager Therapeutics 201901– General Counsel before Foundation Medicine + Genzyme) |
General Counsel / Chief Legal Officer (CLO) |
Voyager Therapeutics Inc. (Nasdaq: VYGR) |
United States (USA) |
| Hetke, Christian (Futalis GmbH 201111– Managing Director + Co-founder) |
Managing Director |
Futalis GmbH |
Germany |
| Hettich, Christof (Kanzlei Rittershaus + Dievini Hopp) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Heuer, Anja (Immatics 201907 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Germany |
| Heuer, Michael (Roche 201810– interim CEO of Roche Diagnostics before Region Head EMEA + Latin America joined BM 1983) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) |
Attorney / Lawyer |
Freshfields (Group) |
United Kingdom (GB) |
| Heumann, Hermann (Silantes GmbH 201902 Managing Director) |
Managing Director |
Silantes GmbH |
|
| Heumann, Klaus (Biomax 200611 CEO) |
Chief Executive Officer (CEO) |
Biomax (Group) |
Germany |
| Heumann, Klaus (Univ Mainz 200701 Professor for Inorganic and Analytical Chemistry) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
| Heydler, Thomas P. (Definiens 200411– CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
Germany |
| Heyne, Wilfried (Humedics GmbH 201110 Managing Director) |
Managing Director |
Humedics GmbH |
Germany |
| Heyse, Stephan (Genedata 200701 Head of Genedata Screener) |
Product Manager (personnel) |
Genedata (Group) |
Switzerland |
| Heß, Markus (Astra Diagnostics 201105 Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
| Heß, Rüdiger (PXBioVision 201104 Managing Director) |
Managing Director |
PXBioVisioN GmbH |
Germany |
| Heßler, Nadine (JeNaCell GmbH 201210 Managing Director) |
Managing Director |
JeNaCell GmbH |
Germany |
| Hibbs, Kathy L. (23andMe 202101 Chief Legal + Regulatory Officer before Genomic Health + Monogram Biosciences) |
General Counsel / Chief Legal Officer (CLO) |
23andMe Inc. |
United States (USA) |
| Hickey, Dave (Siemens 200805 SVP Strategic Planning + BusDev at Siemens Healthcare Diagnostics) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
| Hicks, Dave (Danaher 201004 VP + General Manager Pharmaceuticals + Proteomics at AB SCIEX) |
General Manager (management) |
Danaher (Group) |
Canada |
| Higashi, Shunichi (Miraca 201808 CEO of Srl Inc) |
Chief Executive Officer (CEO) |
Miraca (Group) |
Japan |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 25 26 27 ... 73 74 75 
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
